Brito, Jovy B.
HRN: 27-49-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
CEFUROXIME 1.5GM (VIAL)
11/04/2025
11/11/2025
IV
1.5G
Q8HRS
PAPILLARY THYROID CARCINOMA
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes